FGD5P1

Across TCGA pan-cancer cohorts, FGD5P1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated FGD5P1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher FGD5P1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated FGD5P1 expression acts as an unfavorable survival marker, although some lineages such as UCS and UVM show a favorable association.

UCS, UVM, and MESO are the cancer types where FGD5P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Median	IV	0.952	0.367	.001	92	view →
UVM	OS	Median	All	0.780	0.453	<.001	88	view →
MESO	OS	Quartile	All	0.903	0.388	.003	47	view →
KIRC	DFS	Quartile	All	0.768	0.589	.001	30	view →
DLBC	DFS	Median	All	0.600	0.957	.002	30	view →
ACC	DFS	Tertile	All	0.437	0.739	.001	25	view →
CESC	DFS	Quartile	All	0.921	0.780	.005	22	view →
THCA	DFS	Median	III,IV	0.943	0.847	.006	14	view →
BRCA	OS	Median	All	0.976	0.949	.023	13	view →
ESCA	DFS	Median	III,IV	0.423	0.247	.014	13	view →
CHOL	OS	Tertile	All	0.549	0.930	.028	7	view →
COAD	DFS	Tertile	IV	0.575	0.323	.017	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

FGD5P1–UCS (DFS)

Open the UCS breakdown →